Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer’s Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer’s Disease
Authors
Keywords
-
Journal
ACS Omega
Volume 7, Issue 16, Pages 13861-13869
Publisher
American Chemical Society (ACS)
Online
2022-04-14
DOI
10.1021/acsomega.2c00231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease
- (2021) Ashok Iyaswamy et al. PHYTOMEDICINE
- Phytol loaded PLGA nanoparticles ameliorate scopolamine-induced cognitive dysfunction by attenuating cholinesterase activity, oxidative stress and apoptosis in Wistar rat
- (2020) Sethuraman Sathya et al. NUTRITIONAL NEUROSCIENCE
- The effect of baicalein-loaded Y-shaped miktoarm copolymer on spatial memory and hippocampal expression of DHCR24, SELADIN and SIRT6 genes in rat model of Alzheimer
- (2020) Mozhgan Aghajanzadeh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Neuroprotective effects of clavulanic acid following permanent bilateral common carotid artery occlusion in rats
- (2019) Mustafa Ghanbarabadi et al. DRUG DEVELOPMENT RESEARCH
- The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers
- (2019) Kim San Tang LIFE SCIENCES
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- The influence of age in women in visuo-spatial memory in reaching and navigation tasks with and without landmarks
- (2018) A. Perrochon et al. NEUROSCIENCE LETTERS
- A promising connection between BDNF and Alzheimer’s disease
- (2018) Maria Laura Giuffrida et al. Aging-US
- Is Seladin-1 Really a Selective Alzheimer's Disease Indicator?
- (2018) Laura J. Sharpe et al. JOURNAL OF ALZHEIMERS DISEASE
- Emerging Roles of Sirtuin 6 in Alzheimer’s Disease
- (2017) Nurul Fatihah Mohamad Nasir et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The role of BDNF in Alzheimer's disease
- (2017) Heikki Tanila NEUROBIOLOGY OF DISEASE
- Sirtuin 6 protects the brain from cerebral ischemia/reperfusion injury through NRF2 activation
- (2017) Wei Zhang et al. NEUROSCIENCE
- Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats
- (2017) Hani S. Hafez et al. PSYCHOPHARMACOLOGY
- Impairments of spatial memory in an Alzheimer’s disease model via degeneration of hippocampal cholinergic synapses
- (2017) Houze Zhu et al. Nature Communications
- Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study
- (2017) Sara Ahmadi-Abhari et al. BMJ-British Medical Journal
- Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study
- (2017) Sara Ahmadi-Abhari et al. BMJ-British Medical Journal
- Age and gender-related differences in a spatial memory task in humans
- (2016) Irene León et al. BEHAVIOURAL BRAIN RESEARCH
- Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice
- (2015) Jae Kim et al. AMINO ACIDS
- The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients
- (2015) Nan Zhang et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Memantine Enhances Recovery From Stroke
- (2014) Héctor E. López-Valdés et al. STROKE
- Death by a Thousand Cuts in Alzheimer’s Disease: Hypoxia—The Prodrome
- (2013) Mak Adam Daulatzai NEUROTOXICITY RESEARCH
- Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia
- (2013) Galit Weinstein et al. JAMA Neurology
- Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells
- (2012) Gina Chun Kost et al. BRAIN RESEARCH
- Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and Amyloid precursor protein (AβPP) expression in rat brain
- (2012) SyedWaseem Bihaqi et al. INDIAN JOURNAL OF PHARMACOLOGY
- Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains
- (2012) Celeste M. Karch et al. PLoS One
- Hippocampus and neocortex: recognition and spatial memory
- (2011) Seralynne D Vann et al. CURRENT OPINION IN NEUROBIOLOGY
- Comparative protective action of curcumin, memantine and diclofenac against scopolamine-induced memory dysfunction
- (2011) Elham H.A. Ali et al. FITOTERAPIA
- Clavulanic acid protects neurons in pharmacological models of neurodegenerative diseases
- (2010) Youngbuhm Huh et al. DRUG DEVELOPMENT RESEARCH
- Assessment of spatial memory in mice
- (2010) Sunita Sharma et al. LIFE SCIENCES
- The Genetics of Alzheimer Disease: Back to the Future
- (2010) Lars Bertram et al. NEURON
- Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
- (2010) George Grossberg et al. Clinical Interventions in Aging
- Zeatin Supplement Improves Scopolamine-Induced Memory Impairment in Mice
- (2008) Mi Jeong KIM et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Clavulanic acid: A review
- (2008) Parag S. Saudagar et al. BIOTECHNOLOGY ADVANCES
- Neuroprotective effects of the Alzheimer's disease-related gene seladin-1
- (2008) Alessandro Peri et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- NMDA receptors in clinical neurology: excitatory times ahead
- (2008) Lorraine V Kalia et al. LANCET NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started